Joseph Wu
President at American Heart Association, Inc.
Profile
Joseph C.
Wu is the founder of Stem Cell Theranostics, Inc. founded in 2013.
He is currently the President & Director at American Heart Association, Inc. Dr. Wu holds a doctorate degree from the University of California, Los Angeles and Yale University.
Joseph Wu active positions
| Companies | Position | Start |
|---|---|---|
American Heart Association, Inc.
 American Heart Association, Inc. Miscellaneous Commercial ServicesCommercial Services American Heart Association, Inc. operates a voluntary health organization funded by private contributions. The organization offers services for coronary heart diseases and strokes, high blood cholesterol & physical inactivity, obesity, and diabetes. The company was founded in 1924 and is headquartered in Dallas, TX. | President | - |
Former positions of Joseph Wu
| Companies | Position | End |
|---|---|---|
Stem Cell Theranostics, Inc.
 Stem Cell Theranostics, Inc. BiotechnologyHealth Technology Stem Cell Theranostics, Inc. develops genetically-targeted therapies for genetic and drug-induced heart disease. It offers a discovery platform that focuses on the generation and use of stem cell-derived, patient-specific cardiac models in drug screening and therapeutic development. The company was founded by Andrew Lee, Robert C. Robbins, Divya Nag, and Joseph C. Wu in 2013 and is headquartered in Redwood City, CA. | Founder | - |
Training of Joseph Wu
| University of California, Los Angeles | Doctorate Degree |
| Yale University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
American Heart Association, Inc.
American Heart Association, Inc. Miscellaneous Commercial ServicesCommercial Services American Heart Association, Inc. operates a voluntary health organization funded by private contributions. The organization offers services for coronary heart diseases and strokes, high blood cholesterol & physical inactivity, obesity, and diabetes. The company was founded in 1924 and is headquartered in Dallas, TX. | Commercial Services |
Stem Cell Theranostics, Inc.
Stem Cell Theranostics, Inc. BiotechnologyHealth Technology Stem Cell Theranostics, Inc. develops genetically-targeted therapies for genetic and drug-induced heart disease. It offers a discovery platform that focuses on the generation and use of stem cell-derived, patient-specific cardiac models in drug screening and therapeutic development. The company was founded by Andrew Lee, Robert C. Robbins, Divya Nag, and Joseph C. Wu in 2013 and is headquartered in Redwood City, CA. | Health Technology |
- Stock Market
- Insiders
- Joseph Wu
